104 related articles for article (PubMed ID: 22620859)
1. Toll-like receptor 9 in systemic lupus erythematosus, impact on glucocorticoid treatment.
Ghaly NR; Kotb NA; Nagy HM; Rageh el SM
J Dermatolog Treat; 2013 Dec; 24(6):411-7. PubMed ID: 22620859
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
Mu R; Sun XY; Lim LT; Xu CH; Dai CX; Su Y; Jia RL; Li ZG
Chin Med J (Engl); 2012 Aug; 125(16):2873-7. PubMed ID: 22932083
[TBL] [Abstract][Full Text] [Related]
3. The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.
Wu O; Chen GP; Chen H; Li XP; Xu JH; Zhao SS; Sheng J; Feng JB; Cai J; Fang XH; Zhang WH; Li LH; Zhang N; Li J; Li JJ; Pan FM; Wang CZ; Ye DQ
Immunobiology; 2009; 214(5):392-402. PubMed ID: 19362685
[TBL] [Abstract][Full Text] [Related]
4. Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice.
Lee TP; Huang JC; Liu CJ; Chen HJ; Chen YH; Tsai YT; Yang W; Sun KH
Exp Biol Med (Maywood); 2014 Jun; 239(6):715-23. PubMed ID: 24719374
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare-up.
Liao YN; Liu CS; Tsai TR; Hung YC; Chang SJ; Lin HL; Chen YC; Lai HM; Yu SF; Chen CJ
Kaohsiung J Med Sci; 2011 Jul; 27(7):251-7. PubMed ID: 21757141
[TBL] [Abstract][Full Text] [Related]
6. Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity.
Tanaka A; Tsukamoto H; Mitoma H; Kiyohara C; Ueda N; Ayano M; Ohta S; Inoue Y; Arinobu Y; Niiro H; Horiuchi T; Akashi K
Arthritis Res Ther; 2012 Nov; 14(6):R244. PubMed ID: 23140401
[TBL] [Abstract][Full Text] [Related]
7. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
8. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
[TBL] [Abstract][Full Text] [Related]
9. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation.
Sieber J; Daridon C; Fleischer SJ; Fleischer V; Hiepe F; Alexander T; Heine G; Burmester GR; Fillatreau S; Dörner T
Arthritis Res Ther; 2014 Nov; 16(6):477. PubMed ID: 25385499
[TBL] [Abstract][Full Text] [Related]
10. Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population.
Tao K; Fujii M; Tsukumo S; Maekawa Y; Kishihara K; Kimoto Y; Horiuchi T; Hisaeda H; Akira S; Kagami S; Yasutomo K
Ann Rheum Dis; 2007 Jul; 66(7):905-9. PubMed ID: 17344245
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Toll-Like Receptor 9 Gene Single-Nucleotide Polymorphism to Systemic Lupus Erythematosus in Egyptian Patients.
Shahin RM; El Khateeb E; Khalifa RH; El Refai RM
Immunol Invest; 2016; 45(3):235-42. PubMed ID: 27018624
[TBL] [Abstract][Full Text] [Related]
12. Correlation between TLR9 Expression and Cytokine Secretion in the Clinical Diagnosis of Systemic Lupus Erythematosus.
Rao H; Zeng Q; Liang Y; Xiao C; Xie S; Xu X
Mediators Inflamm; 2015; 2015():710720. PubMed ID: 26457008
[TBL] [Abstract][Full Text] [Related]
13. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
14. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
Machida H; Ito S; Hirose T; Takeshita F; Oshiro H; Nakamura T; Mori M; Inayama Y; Yan K; Kobayashi N; Yokota S
Nephrol Dial Transplant; 2010 Aug; 25(8):2530-537. PubMed ID: 20181802
[TBL] [Abstract][Full Text] [Related]
15. The effect of methotrexate on improving serological abnormalities of patients with systemic lupus erythematosus.
Miyawaki S; Nishiyama S; Aita T; Yoshinaga Y
Mod Rheumatol; 2013 Jul; 23(4):659-66. PubMed ID: 23011357
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus.
Du J; Li M; Zhang D; Zhu X; Zhang W; Gu W; Feng Y; Zhai X; Ling C
Arthritis Res Ther; 2009; 11(4):R108. PubMed ID: 19594946
[TBL] [Abstract][Full Text] [Related]
17. Negative relationship between expression of glucocorticoid receptor alpha and disease activity: glucocorticoid treatment of patients with systemic lupus erythematosus.
Li X; Zhang FS; Zhang JH; Wang JY
J Rheumatol; 2010 Feb; 37(2):316-21. PubMed ID: 20032106
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia in males with systemic lupus erythematosus.
Mok CC; Lau CS; Lee KW; Wong RW
J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430
[TBL] [Abstract][Full Text] [Related]
19. Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population.
Zhang J; Zhu Q; Meng F; Lei H; Zhao Y
Gene; 2014 Jan; 533(1):385-8. PubMed ID: 24004541
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
Nguyen CP; Cao VV; Fehér J; Gergely P
Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
